PHARMACODYNAMIC MODELING OF FINASTERIDE, A 5-ALPHA-REDUCTASE INHIBITOR

被引:0
作者
KO, JC [1 ]
JUSKO, WJ [1 ]
机构
[1] SUNY BUFFALO,SCH PHARM,DEPT PHARMACEUT,BUFFALO,NY 14260
来源
PHARMACOTHERAPY | 1995年 / 15卷 / 04期
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Finasteride is a 4-azasteroid inhibitor of one isoenzyme of 5 alpha-reductases that converts testosterone to dihydrotestosterone (DHT). We characterized the time course of DHT concentrations. The following model was used to assess DHT pharmacodynamics: [GRAPHICS] where joint fitting of three dose levels yielded k(in)(0) = 28% change/hour, k(out) = 0.28 hour(-1), IC50 = 0.012 ng/ml, and E(max) = 0.7. The modification of a previous model with the maximum partial effect factor, E(max), may be useful in characterizing the pharmacodynamics of drugs with similar indirect mechanisms.
引用
收藏
页码:509 / 511
页数:3
相关论文
共 10 条
[1]   ANDROGEN-REGULATED GENE-EXPRESSION [J].
BERGER, FG ;
WATSON, G .
ANNUAL REVIEW OF PHYSIOLOGY, 1989, 51 :51-65
[2]  
BRUCHOVSKY N, 1968, J BIOL CHEM, V243, P2012
[3]  
CARLIN JR, 1992, DRUG METAB DISPOS, V20, P148
[4]   COMPARISON OF 4 BASIC MODELS OF INDIRECT PHARMACODYNAMIC RESPONSES [J].
DAYNEKA, NL ;
GARG, V ;
JUSKO, WJ .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1993, 21 (04) :457-478
[5]   FINASTERIDE - A SLOW-BINDING 5-ALPHA-REDUCTASE INHIBITOR [J].
FALLER, B ;
FARLEY, D ;
NICK, H .
BIOCHEMISTRY, 1993, 32 (21) :5705-5710
[6]   EFFECTS OF FINASTERIDE (MK-906), A 5-ALPHA-REDUCTASE INHIBITOR, ON CIRCULATING ANDROGENS IN MALE-VOLUNTEERS [J].
GORMLEY, GJ ;
STONER, E ;
RITTMASTER, RS ;
GREGG, H ;
THOMPSON, DL ;
LASSETER, KC ;
VLASSES, PH ;
STEIN, EA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 70 (04) :1136-1141
[7]   GENETIC AND PHARMACOLOGICAL EVIDENCE FOR MORE THAN ONE HUMAN STEROID 5-ALPHA-REDUCTASE [J].
JENKINS, EP ;
ANDERSSON, S ;
IMPERATOMCGINLEY, J ;
WILSON, JD ;
RUSSELL, DW .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (01) :293-300
[8]   SPECIES-DIFFERENCES IN PROSTATIC STEROID 5-ALPHA-REDUCTASES OF RAT, DOG, AND HUMAN [J].
LIANG, T ;
CASCIERI, MA ;
CHEUNG, AH ;
REYNOLDS, GF ;
RASMUSSON, GH .
ENDOCRINOLOGY, 1985, 117 (02) :571-579
[9]   PHARMACOKINETICS AND BIOCHEMICAL EFFICACY AFTER SINGLE AND MULTIPLE ORAL-ADMINISTRATION OF N-(2-METHYL-2-PROPYL)-3-OXO-4-AZA-5-ALPHA-ANDROST-1-ENE-17-BETA-CARBOXAMIDE, A NEW TYPE OF SPECIFIC COMPETITIVE INHIBITOR OF TESTOSTERONE 5-ALPHA-REDUCTASE, IN VOLUNTEERS [J].
OHTAWA, M ;
MORIKAWA, H ;
SHIMAZAKI, J .
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1991, 16 (01) :15-21
[10]  
SUDDUTH SL, 1993, PHARMACOTHERAPY, V13, P309